111614
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
子痫前期患者血清尿酸水平与凝血功能障碍关系的研究进展
Authors Zou M, Tang D, Liu F, Guan F
Received 31 July 2025
Accepted for publication 18 November 2025
Published 28 November 2025 Volume 2025:17 Pages 5007—5015
DOI https://doi.org/10.2147/IJWH.S557385
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Everett Magann
Mengjun Zou,1,2 Dongmei Tang,2 Fang Liu,2 Feng Guan2
1Zhongshan Clinical Medical College, Dalian University, Dalian, Liaoning, 116001, People’s Republic of China; 2Department of Obstetrics, Zhongshan Hospital Affiliated to Dalian University, Dalian, Liaoning, 116001, People’s Republic of China
Correspondence: Mengjun Zou, Email mengjun000908@163.com
Abstract: Preeclampsia (PE) is a pregnancy-specific complication that typically occurs in the mid to late stages of gestation. Its main clinical features include gestational hypertension, proteinuria, and multiple organ dysfunction. In severe cases, it may progress to eclampsia, HELLP syndrome, and even pose life-threatening risks to both mother and fetus. Recent studies have found that serum uric acid (UA) levels are significantly elevated in patients with PE and closely correlated with disease severity, suggesting that UA may not only serve as a metabolic marker but also play an active role in the pathogenesis of PE. At the same time, coagulation dysfunction—an important pathological feature of PE—manifests as thrombocytopenia, consumption of coagulation factors, suppression of the fibrinolytic system, and microthrombus formation. These changes contribute significantly to organ damage and adverse pregnancy outcomes in PE. This review summarizes the dynamic changes in serum uric acid levels during PE and explores their relationship with coagulation abnormalities. Particular emphasis is placed on the potential mechanisms by which uric acid induces coagulation disorders, including endothelial cell injury, oxidative stress aggravation, and activation of inflammatory pathways. Additionally, the review discusses the clinical utility of various coagulation-related biomarkers (such as D-dimer, fibrinogen, PAI-1, and P-selectin) in the early prediction, severity assessment, and clinical management of PE. Current research indicates that combined monitoring of serum uric acid and coagulation markers—for instance, models integrating UA with the sFlt-1/PlGF ratio or with PAI-1, which have demonstrated high predictive accuracy (AUC > 0.90) for early-onset PE—may improve early detection and risk stratification. However, the current evidence remains primarily observational and is limited by heterogeneity in study designs. Future studies should prioritize well-designed prospective cohorts to clarify causal relationships and explore more sensitive and specific combined predictive models to provide a stronger theoretical and clinical foundation for improving maternal and fetal outcomes.
Keywords: preeclampsia, serum uric acid, coagulation dysfunction, endothelial injury, inflammatory response, hypercoagulable state, predictive model
1Zhongshan Clinical Medical College, Dalian University, Dalian, Liaoning, 116001, People’s Republic of China; 2Department of Obstetrics, Zhongshan Hospital Affiliated to Dalian University, Dalian, Liaoning, 116001, People’s Republic of China
Correspondence: Mengjun Zou, Email mengjun000908@163.com
Abstract: Preeclampsia (PE) is a pregnancy-specific complication that typically occurs in the mid to late stages of gestation. Its main clinical features include gestational hypertension, proteinuria, and multiple organ dysfunction. In severe cases, it may progress to eclampsia, HELLP syndrome, and even pose life-threatening risks to both mother and fetus. Recent studies have found that serum uric acid (UA) levels are significantly elevated in patients with PE and closely correlated with disease severity, suggesting that UA may not only serve as a metabolic marker but also play an active role in the pathogenesis of PE. At the same time, coagulation dysfunction—an important pathological feature of PE—manifests as thrombocytopenia, consumption of coagulation factors, suppression of the fibrinolytic system, and microthrombus formation. These changes contribute significantly to organ damage and adverse pregnancy outcomes in PE. This review summarizes the dynamic changes in serum uric acid levels during PE and explores their relationship with coagulation abnormalities. Particular emphasis is placed on the potential mechanisms by which uric acid induces coagulation disorders, including endothelial cell injury, oxidative stress aggravation, and activation of inflammatory pathways. Additionally, the review discusses the clinical utility of various coagulation-related biomarkers (such as D-dimer, fibrinogen, PAI-1, and P-selectin) in the early prediction, severity assessment, and clinical management of PE. Current research indicates that combined monitoring of serum uric acid and coagulation markers—for instance, models integrating UA with the sFlt-1/PlGF ratio or with PAI-1, which have demonstrated high predictive accuracy (AUC > 0.90) for early-onset PE—may improve early detection and risk stratification. However, the current evidence remains primarily observational and is limited by heterogeneity in study designs. Future studies should prioritize well-designed prospective cohorts to clarify causal relationships and explore more sensitive and specific combined predictive models to provide a stronger theoretical and clinical foundation for improving maternal and fetal outcomes.
Keywords: preeclampsia, serum uric acid, coagulation dysfunction, endothelial injury, inflammatory response, hypercoagulable state, predictive model